Topics

Articles

Biopharma sponsorship of patient-support programs and treatments for rare diseases is growing, but gaps remain 

New book attempts to cut through pharma’s patient-centric posturing and start a conversation about real, transformational change

Not quite specialty, not quite retail: Cost-effective access and support strategies for a growing, yet underserved, treatment market

The patient-first, pharmacy-first hub model optimizes outcomes and improves care journey for patients with rare disease

Disruption is the order of the day to create a more individual-centric hub experience from the patient’s point of view

A conversation with Ian Riches, head of patient solutions for Europe,
Ashfield Engage

The need for supporting services in copay accumulator and best price areas

Creating positive experiences and other patient-focused strategies for sponsors to consider when planning and executing cancer studies

It's time to include hubs in the patient treatment journey